• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种氟喹诺酮类药物对86株分枝杆菌的体外活性

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.

作者信息

Texier-Maugein J, Mormède M, Fourche J, Bébéar C

机构信息

Laboratoire de Bactériologie, Hôpital Xavier-Arnozan, Pessac, Bordeaux, France.

出版信息

Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.

DOI:10.1007/BF02014255
PMID:3125050
Abstract

The in vitro activity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin against 86 strains of mycobacteria was evaluated by broth dilution. While Mycobacterium avium, Mycobacterium scrofulaceum and Mycobacterium chelonae were resistant to all four antibacterials, the susceptibility of the other species, Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium xenopi and Mycobacterium fortuitum, depended on the antibiotic. Ofloxacin and ciprofloxacin (MIC90: 0.5 - 2 mg/l) were more active than pefloxacin and norfloxacin (MIC90: 2 - 16 mg/l).

摘要

采用肉汤稀释法评估了培氟沙星、诺氟沙星、氧氟沙星和环丙沙星对86株分枝杆菌的体外活性。鸟分枝杆菌、瘰疬分枝杆菌和龟分枝杆菌对这四种抗菌药物均耐药,而其他菌种,如结核分枝杆菌、堪萨斯分枝杆菌、偶发分枝杆菌和嗜肺分枝杆菌的药敏情况则取决于抗生素种类。氧氟沙星和环丙沙星(MIC90:0.5 - 2mg/L)比培氟沙星和诺氟沙星(MIC90:2 - 16mg/L)活性更强。

相似文献

1
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.四种氟喹诺酮类药物对86株分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.
2
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.五种氟喹诺酮类药物对分枝杆菌的体外活性比较
J Antimicrob Chemother. 1987 May;19(5):605-9. doi: 10.1093/jac/19.5.605.
3
Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.五种氟喹诺酮类药物对鸟分枝杆菌复合群和偶发分枝杆菌的活性。
Ann Inst Pasteur Microbiol. 1988 Mar-Apr;139(2):233-7. doi: 10.1016/0769-2609(88)90008-7.
4
[Sensitivity of 7 mycobacterial species to new quinolones].[7种分枝杆菌对新型喹诺酮类药物的敏感性]
Pathol Biol (Paris). 1988 May;36(5):477-81.
5
[In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].[分枝杆菌对氟喹诺酮类药物敏感性的体外测定]
Pathol Biol (Paris). 1989 May;37(5):346-9.
6
In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.偶然分枝杆菌、龟分枝杆菌和鸟分枝杆菌对某些喹诺酮类药物的体外敏感性。
Chemioterapia. 1987 Dec;6(6):431-3.
7
In vitro activity of five new quinolones against cultivable mycobacteria.五种新型喹诺酮类药物对可培养分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):572-3. doi: 10.1007/BF02014249.
8
[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].环丙沙星和氧氟沙星对结核分枝杆菌、鸟分枝杆菌、非洲分枝杆菌、堪萨斯分枝杆菌及卡介苗菌株的体外活性
Immun Infekt. 1986 Nov;14(6):203-7.
9
Preliminary study of the in vitro activity of irloxacin against mycobacteria.依诺沙星对分枝杆菌体外活性的初步研究。
Chemotherapy. 1995 May-Jun;41(3):204-7. doi: 10.1159/000239345.
10
Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.环丙沙星对分枝杆菌的体外活性:BACTEC法与大管肉汤稀释法的比较
J Antimicrob Chemother. 1987 May;19(5):617-22. doi: 10.1093/jac/19.5.617.

引用本文的文献

1
Resistance status of Mycobacterium tuberculosis on the island of Crete, Greece.希腊克里特岛结核分枝杆菌的耐药状况。
Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):607-9. doi: 10.1007/s10096-007-0341-1.
2
Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.环境分枝杆菌对抗菌剂诺氟沙星的转化作用。
Appl Environ Microbiol. 2006 Sep;72(9):5790-3. doi: 10.1128/AEM.03032-05.
3
Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.阿米卡星和氧氟沙星对偶然分枝杆菌的抗生素后效应。

本文引用的文献

1
In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.新型抗菌物质DL-8280的体外抗分枝杆菌活性——通过DL-8280药敏试验鉴别分枝杆菌某些菌种及相关菌属
Microbiol Immunol. 1983;27(12):1129-32. doi: 10.1111/j.1348-0421.1983.tb02933.x.
2
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.诺氟沙星和环丙沙星对结核分枝杆菌、鸟分枝杆菌复合体、龟分枝杆菌、偶然分枝杆菌和堪萨斯分枝杆菌的体外活性。
Antimicrob Agents Chemother. 1984 Jul;26(1):94-6. doi: 10.1128/AAC.26.1.94.
3
Antimicrob Agents Chemother. 1993 May;37(5):1001-3. doi: 10.1128/AAC.37.5.1001.
4
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages.左氧氟沙星对结核分枝杆菌的体外及在人巨噬细胞中的抑制和杀菌活性。
Antimicrob Agents Chemother. 1994 May;38(5):1161-4. doi: 10.1128/AAC.38.5.1161.
5
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
6
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.
7
Mycobacteria and the new quinolones.分枝杆菌与新型喹诺酮类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.
8
MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.Win 57273对鸟分枝杆菌和结核分枝杆菌的最低抑菌浓度(MICs)和最低杀菌浓度(MBCs)
Antimicrob Agents Chemother. 1990 May;34(5):770-4. doi: 10.1128/AAC.34.5.770.
9
Newly documented antimicrobial activity of quinolones.喹诺酮类药物新记录的抗菌活性。
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):249-54. doi: 10.1007/BF01966997.
Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.
新型抗菌物质氧氟沙星(DL8280)对肺结核的治疗作用
Am Rev Respir Dis. 1985 Mar;131(3):352-6. doi: 10.1164/arrd.1985.131.3.352.
4
[Salvage treatment of multi-resistant pulmonary tuberculosis. Efficacy of pefloxacine].[多重耐药肺结核的挽救治疗。培氟沙星的疗效]
Presse Med. 1987 Jan 31;16(3):128.
5
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.环丙沙星及其他4-喹诺酮类药物对结核分枝杆菌和胞内分枝杆菌的体外活性比较
Antimicrob Agents Chemother. 1986 Mar;29(3):386-8. doi: 10.1128/AAC.29.3.386.
6
In-vitro susceptibility of mycobacteria to ciprofloxacin.分枝杆菌对环丙沙星的体外敏感性
J Antimicrob Chemother. 1985 Nov;16(5):575-80. doi: 10.1093/jac/16.5.575.